Table 1.
Baseline characteristics of participants in the assessment of family planning practices at 6 hospitals in Thailand, 2008-2009
Characteristics | Total (N = 1,388) | Male (n = 737; 53.1 %) | Female (n = 651; 46.9 %) |
---|---|---|---|
No. (%) | No. (%) | No. (%) | |
Hospital | |||
Vajira (BKK) | 202 (14.6) | 102 (13.8) | 100 (15.4) |
Taksin (BKK) | 165 (11.9) | 99 (13.4) | 66 (10.1) |
Rajavithi (BKK) | 93 (6.7) | 29 (3.9) | 64 (9.8) |
Siriraj (BKK) | 250 (18.0) | 110 (14.9) | 140 (21.5) |
Bamrasnaradura Infectious Diseases Institute (Nonthaburi) | 588 (42.4) | 343 (46.5) | 245 (37.6) |
Viangpapao (Chiang Rai) | 90 (6.5) | 54 (7.3) | 36 (5.5) |
Age | |||
Median age in years (IQR) | 37 (33, 43) | 39 (34, 45) | 35 (32, 40) |
18–29 years old | 164 (11.8) | 69 (9.4) | 95 (14.6) |
30–39 years old | 677 (48.8) | 310 (42.1) | 367 (56.4) |
40–49 years old | 447 (32.2) | 258 (35.0) | 189 (29.0) |
> 50 years old | 100 (7.2) | 100 (13.6) | 0 (0.0) |
Education group | |||
≤ Primary school | 533 (38.4) | 257 (34.9) | 276 (42.4) |
> Primary school | 853 (61.5) | 478 (64.9) | 375 (57.6) |
Missing | 2 (0.1) | 2 (0.3) | 0 (0.0) |
Marital status | |||
Single | 301 (21.7) | 253 (34.3) | 48 (7.4) |
Married with and/or Live in partner | 776 (55.9) | 372 (50.5) | 404 (62.1) |
Divorced or Separated | 311 (22.4) | 112 (15.2) | 199 (30.5) |
Years since HIV diagnosis | |||
Median (IQR) | 5 (2, 8) | 5 (2, 7) | 5 (2, 9) |
< 1 year | 120 (8.7) | 61 (8.4) | 59 (9.1) |
1 to less than 5 years | 529 (38.5) | 298 (40.9) | 231 (35.8) |
≥ 5 years | 726 (52.8) | 370 (50.8) | 356 (55.1) |
Missing | 13 | 8 | 5 |
On ART | |||
Yes | 1,157 (99.7) | 649 (99.7) | 508 (99.8) |
No | 3 (0.3) | 2 (0.3) | 1 (0.2) |
Missing | 228 | 86 | 142 |
CD4 count at baselinea | |||
Median (IQR) cells/mmb | 343 (201–502) | 326 (181–475) | 376 (225–530) |
Viral loadc | |||
Median (IQR) copies/mL | 50 (40–50) | 50 (40–50) | 50 (40–50) |
Received short messages relating to family planning at enrollment (PLHIV may receive messages from many staff) | |||
From doctor | 927 (66.8) | 514 (69.7) | 413 (63.4) |
From nurse | 455 (32.8) | 258 (35.0) | 197 (30.3) |
From counselor | 1,042 (75.1) | 571 (77.5) | 471 (72.4) |
Have steady partner | |||
No | 490 (35.3) | 290 (39.3) | 200 (30.7) |
Yes | 898 (64.7) | 447 (60.7) | 451 (69.3) |
Among PLHIV with steady partner (n = 898) | |||
Intention to become pregnant in the future | |||
Yes | 36 (4.0) | 13 (2.9) | 23 (5.1) |
No | 862 (96.0) | 434 (97.1) | 428 (94.9) |
Disclosed HIV status to steady partner | 765 (85.2) | 385 (86.1) | 380 (84.3) |
Steady partner HIV status | |||
Positive | 385 (42.9) | 183 (40.9) | 201 (44.6) |
Negative | 288 (32.1) | 161 (36.0) | 127 (28.2) |
Unknown | 225 (25.1) | 103 (23.0) | 123 (27.3) |
Among PLHIV with steady partner who had sex during the previous 3 months and had not had sterilization (n = 558) | 558 | 291 | 267 |
Intention to become pregnant in the future | |||
Yes | 34 (6.1) | 13 (4.5) | 21 (7.9) |
No | 524 (93.9) | 278 (95.5) | 246 (92.1) |
Among 862 PLHIV not planning to become pregnant in the future | |||
Had sex during the previous 3 months | 709 (82.3) | 352 (81.1) | 357 (83.4) |
Contraceptive used during the past 3 monthsb | 683 (96.3) | 341 (96.9) | 342 (95.8) |
If contraceptive used (n = 683), methods used | |||
Single method used | 481 (70.4) | 257 (75.4) | 224 (65.5) |
Oral pills | 12 (2.5) | 4 (1.6) | 8 (3.6) |
Hormonal injection | 4 (0.8) | 0 (0.0) | 4 (1.8) |
Hormonal implantation | 6 (1.2) | 0 (0.0) | 6 (1.2) |
Sterilization | 37 (7.7) | 10 (3.9) | 27 (12.0) |
Condom | 422 (87.7) | 243 (94.6) | 179 (79.9) |
Intrauterine device | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Two or more methods usedd | 202 (29.6) | 84 (24.5) | 118 (34.2) |
Condom and sterilization | 141 (69.8) | 63 (75.0) | 78 (66.1) |
Condom and oral pills | 36 (17.8) | 13 (15.5) | 23 (19.5) |
Condom and hormonal implantation | 16 (7.9) | 3 (3.6) | 16 (13.6) |
Condom and hormonal injection | 10 (5.0) | 5 (6.0) | 5 (4.2) |
Condom and oral pills and hormonal injection | 1 (0.5) | 0 (0.0) | 1 (0.8) |
aNumber of participants with CD4 count data = 1,200 persons
bSelf or partner
cNumber of participants with viral load data = 719 persons
dPill/hormonal injection/hormonal implantation/male or female sterilization/condom/intrauterine device
Numbers might not sum to 100 % due to rounding